Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 28, 2018 Filed Jul 2, 2018 23:26 UTC |
Chen IvanDirector
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001209191-18-040506 · doc4.xml · derivative · entry 2 Chen Ivan · CIK 0001743729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2028-06-28 F2 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020. Read SEC document |
| June 28, 2018 Filed Jul 2, 2018 23:26 UTC |
Chen IvanDirector
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-040506 · doc4.xml · nonDerivative · entry 1 Chen Ivan · CIK 0001743729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:19 UTC |
Pfanzelter David JDirector · Chairman of the Board
|
GrantStock Options (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001209191-18-014705 · doc4.xml · derivative · entry 1 Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2023-02-26 F1 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:18 UTC |
Otis WilliamDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001209191-18-014700 · doc4.xml · derivative · entry 1 Otis William · CIK 0001589472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-02-27 F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:17 UTC |
Lee Tom YDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001209191-18-014698 · doc4.xml · derivative · entry 1 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-02-27 F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:16 UTC |
Lambert Henry R.Director · Chief Executive Officer
|
GrantStock Options (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001209191-18-014696 · doc4.xml · derivative · entry 1 Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2023-02-26 F1 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:15 UTC |
Hagen ElisabethDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001209191-18-014693 · doc4.xml · derivative · entry 1 Hagen Elisabeth · CIK 0001721211 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-02-27 F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:14 UTC |
Field Janet RisiDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001209191-18-014692 · doc4.xml · derivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-02-27 F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:13 UTC |
Elliott Mark StuartVice President, Finance
|
GrantStock Options (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001209191-18-014690 · doc4.xml · derivative · entry 3 Elliott Mark Stuart · CIK 0001649406 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2021-05-11 F2 · kind: The two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 11, 2016 with an exercise period of 2 years. The term of the option has been amended to extend the exercise period to five years from the date of grant. F3 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on August 11, 2016. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:13 UTC |
Elliott Mark StuartVice President, Finance
|
Disposition to issuerStock Options (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001209191-18-014690 · doc4.xml · derivative · entry 2 Elliott Mark Stuart · CIK 0001649406 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2018-05-11 F2 · kind: The two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 11, 2016 with an exercise period of 2 years. The term of the option has been amended to extend the exercise period to five years from the date of grant. F3 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on August 11, 2016. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:13 UTC |
Elliott Mark StuartVice President, Finance
|
GrantStock Options (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001209191-18-014690 · doc4.xml · derivative · entry 1 Elliott Mark Stuart · CIK 0001649406 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2023-02-26 F1 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:10 UTC |
Cohee GaryDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001209191-18-014687 · doc4.xml · derivative · entry 1 Cohee Gary · CIK 0001453116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-02-27 F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020. Read SEC document |
| January 12, 2018 Filed Jan 12, 2018 22:38 UTC |
Lambert Henry R.Director · Chief Executive Officer
|
SaleCommon Stock | 11,323 | $0.90 | $10,190.70 |
DisclosureSEC source: 0001209191-18-003458 · doc4.xml · nonDerivative · entry 5 Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,056 Read SEC document |
| January 12, 2018 Filed Jan 12, 2018 22:38 UTC |
Lambert Henry R.Director · Chief Executive Officer
|
SaleCommon Stock | 9,000 | $0.94 | $8,460.00 |
DisclosureSEC source: 0001209191-18-003458 · doc4.xml · nonDerivative · entry 4 Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509,379 Read SEC document |
| January 12, 2018 Filed Jan 12, 2018 22:38 UTC |
Lambert Henry R.Director · Chief Executive Officer
|
SaleCommon Stock | 677 | $0.93 | $629.61 |
DisclosureSEC source: 0001209191-18-003458 · doc4.xml · nonDerivative · entry 3 Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 518,379 Read SEC document |
| January 11, 2018 Filed Jan 12, 2018 22:38 UTC |
Lambert Henry R.Director · Chief Executive Officer
|
SaleCommon Stock | 2,000 | $0.94 | $1,880.00 |
DisclosureSEC source: 0001209191-18-003458 · doc4.xml · nonDerivative · entry 2 Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,056 Read SEC document |
| January 10, 2018 Filed Jan 12, 2018 22:38 UTC |
Lambert Henry R.Director · Chief Executive Officer
|
SaleCommon Stock | 18,500 | $0.94 | $17,390.00 |
DisclosureSEC source: 0001209191-18-003458 · doc4.xml · nonDerivative · entry 1 Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 521,056 Read SEC document |
| December 29, 2017 Filed Dec 29, 2017 22:12 UTC |
Lee Tom YDirector
|
PurchaseWarrant · Derivative | 2,133,333 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001209191-17-067662 · doc4.xml · derivative · entry 4 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Plum Investments, L.P. Disclosed balance after: 2,133,333 Underlying: Common Stock · 2,133,333 shares Expires 2019-08-29 F1 · kind: Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70. F1 · price: Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70. F2 · ownership.nature: Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P. Read SEC document |
| December 29, 2017 Filed Dec 29, 2017 22:12 UTC |
Lee Tom YDirector
|
PurchaseCommon Stock | 18,666,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-067662 · doc4.xml · nonDerivative · entry 1 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Plum Investments, L.P. Disclosed balance after: 18,666,666 F1 · kind: Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70. F1 · price: Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70. F2 · ownership.nature: Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P. Read SEC document |
| December 29, 2017 Filed Dec 29, 2017 22:11 UTC |
Franchise Brands, LLC10% owner
|
SaleWarrant · Derivative | 2,133,333 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001209191-17-067658 · doc4.xml · derivative · entry 2 Franchise Brands, LLC · CIK 0001618371 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,133,333 shares Expires 2019-08-22 F1 · kind: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70. F1 · price: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70. Read SEC document |
| December 29, 2017 Filed Dec 29, 2017 22:11 UTC |
Franchise Brands, LLC10% owner
|
SaleCommon Stock | 18,666,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-067658 · doc4.xml · nonDerivative · entry 1 Franchise Brands, LLC · CIK 0001618371 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70. F1 · price: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70. Read SEC document |
| November 02, 2017 Filed Nov 3, 2017 21:12 UTC |
Hagen ElisabethDirector
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001209191-17-059249 · doc4.xml · derivative · entry 2 Hagen Elisabeth · CIK 0001721211 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-11-02 F2 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Read SEC document |
| November 02, 2017 Filed Nov 3, 2017 21:12 UTC |
Hagen ElisabethDirector
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-059249 · doc4.xml · nonDerivative · entry 1 Hagen Elisabeth · CIK 0001721211 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:17 UTC |
Pfanzelter David JDirector · Chairman of the Board
|
Exercise / conversionWarrant · Derivative | 16,000 | Not disclosed Strike: $0.60 | Not disclosed |
DisclosureSEC source: 0001209191-17-054171 · doc4.xml · derivative · entry 4 Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2017-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017. F2 · price: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:17 UTC |
Pfanzelter David JDirector · Chairman of the Board
|
GrantWarrant · Derivative | 16,000 | Not disclosed Strike: $0.60 | Not disclosed |
DisclosureSEC source: 0001209191-17-054171 · doc4.xml · derivative · entry 3 Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2017-09-25 F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:17 UTC |
Pfanzelter David JDirector · Chairman of the Board
|
Disposition to issuerWarrant · Derivative | 16,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001209191-17-054171 · doc4.xml · derivative · entry 2 Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2019-07-02 F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:17 UTC |
Pfanzelter David JDirector · Chairman of the Board
|
Exercise / conversionCommon Stock | 16,000 | $0.60 | $9,600.00 |
DisclosureSEC source: 0001209191-17-054171 · doc4.xml · nonDerivative · entry 1 Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:14 UTC |
Otis WilliamDirector
|
Exercise / conversionWarrant · Derivative | 9,066 | Not disclosed Strike: $0.60 | Not disclosed |
DisclosureSEC source: 0001209191-17-054170 · doc4.xml · derivative · entry 4 Otis William · CIK 0001589472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,066 shares Expires 2017-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017. F2 · price: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:14 UTC |
Otis WilliamDirector
|
GrantWarrant · Derivative | 9,066 | Not disclosed Strike: $0.60 | Not disclosed |
DisclosureSEC source: 0001209191-17-054170 · doc4.xml · derivative · entry 3 Otis William · CIK 0001589472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,066 Underlying: Common Stock · 9,066 shares Expires 2017-09-25 F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:14 UTC |
Otis WilliamDirector
|
Disposition to issuerWarrant · Derivative | 9,066 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001209191-17-054170 · doc4.xml · derivative · entry 2 Otis William · CIK 0001589472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,066 shares Expires 2019-08-01 F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:14 UTC |
Otis WilliamDirector
|
Exercise / conversionCommon Stock | 9,066 | $0.60 | $5,439.60 |
DisclosureSEC source: 0001209191-17-054170 · doc4.xml · nonDerivative · entry 1 Otis William · CIK 0001589472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:13 UTC |
Lee Tom YDirector
|
Exercise / conversionWarrant · Derivative | 166,666 | Not disclosed Strike: $0.40 | Not disclosed |
DisclosureSEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 8 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 0 Underlying: Common Stock · 166,666 shares Expires 2017-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised her 2015 Warrant in full and in cash on September 25, 2017. F4 · price: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised her 2015 Warrant in full and in cash on September 25, 2017. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:13 UTC |
Lee Tom YDirector
|
GrantWarrant · Derivative | 166,666 | Not disclosed Strike: $0.40 | Not disclosed |
DisclosureSEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 7 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 166,666 Underlying: Common Stock · 166,666 shares Expires 2017-09-25 F3 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended. F3 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:13 UTC |
Lee Tom YDirector
|
Disposition to issuerWarrant · Derivative | 166,666 | Not disclosed Strike: $0.45 | Not disclosed |
DisclosureSEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 6 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 0 Underlying: Common Stock · 166,666 shares Expires 2020-11-23 F3 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended. F3 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:13 UTC |
Lee Tom YDirector
|
Exercise / conversionWarrant · Derivative | 320,000 | Not disclosed Strike: $0.60 | Not disclosed |
DisclosureSEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 5 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 320,000 shares Expires 2017-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017. F2 · price: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:13 UTC |
Lee Tom YDirector
|
GrantWarrant · Derivative | 320,000 | Not disclosed Strike: $0.60 | Not disclosed |
DisclosureSEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 4 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2017-09-25 F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:13 UTC |
Lee Tom YDirector
|
Disposition to issuerWarrant · Derivative | 320,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 3 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 320,000 shares Expires 2019-08-29 F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:13 UTC |
Lee Tom YDirector
|
Exercise / conversionCommon Stock | 166,666 | $0.40 | $66,666.40 |
DisclosureSEC source: 0001209191-17-054169 · doc4.xml · nonDerivative · entry 2 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 717,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 22:13 UTC |
Lee Tom YDirector
|
Exercise / conversionCommon Stock | 320,000 | $0.60 | $192,000.00 |
DisclosureSEC source: 0001209191-17-054169 · doc4.xml · nonDerivative · entry 1 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,154,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2017 Filed Oct 10, 2017 21:52 UTC Amendment |
Lee Tom YDirector
|
Exercise / conversionWarrant · Derivative | 208,038 | Not disclosed Strike: $0.40 | Not disclosed |
DisclosureSEC source: 0001209191-17-056515 · doc4a.xml · derivative · entry 4 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 208,038 shares Expires 2017-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The original Form 4 Report filed on September 27, 2017 inadvertently omitted the amendment and exercise of an additional warrant. F3 · kind: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2015 Warrant in full and in cash on September 25, 2017. F3 · price: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2015 Warrant in full and in cash on September 25, 2017. Read SEC document |
| September 25, 2017 Filed Oct 10, 2017 21:52 UTC Amendment |
Lee Tom YDirector
|
GrantWarrant · Derivative | 208,038 | Not disclosed Strike: $0.40 | Not disclosed |
DisclosureSEC source: 0001209191-17-056515 · doc4a.xml · derivative · entry 3 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,038 Underlying: Common Stock · 208,038 shares Expires 2017-09-25 F1 · security: The original Form 4 Report filed on September 27, 2017 inadvertently omitted the amendment and exercise of an additional warrant. F2 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended. F2 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended. Read SEC document |
| September 25, 2017 Filed Oct 10, 2017 21:52 UTC Amendment |
Lee Tom YDirector
|
Disposition to issuerWarrant · Derivative | 208,038 | Not disclosed Strike: $0.45 | Not disclosed |
DisclosureSEC source: 0001209191-17-056515 · doc4a.xml · derivative · entry 2 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 208,038 shares Expires 2020-11-23 F1 · security: The original Form 4 Report filed on September 27, 2017 inadvertently omitted the amendment and exercise of an additional warrant. F2 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended. F2 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended. Read SEC document |
| September 25, 2017 Filed Oct 10, 2017 21:52 UTC Amendment |
Lee Tom YDirector
|
Exercise / conversionCommon Stock | 208,038 | $0.40 | $83,215.20 |
DisclosureSEC source: 0001209191-17-056515 · doc4a.xml · nonDerivative · entry 1 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,362,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The original Form 4 Report filed on September 27, 2017 inadvertently omitted the amendment and exercise of an additional warrant. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 23:19 UTC |
Field Janet RisiDirector
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001209191-17-050214 · doc4.xml · derivative · entry 2 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-08-23 F2 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 23:19 UTC |
Field Janet RisiDirector
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-050214 · doc4.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,140 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 20:59 UTC |
Pfanzelter David JDirector · Chairman of the Board
|
GrantStock Options (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001209191-17-041856 · doc4.xml · derivative · entry 2 Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2027-06-22 F3 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable on December 31, 2018 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 20:59 UTC |
Pfanzelter David JDirector · Chairman of the Board
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041856 · doc4.xml · nonDerivative · entry 1 Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,000 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest on December 31, 2018 with the remaining shares vesting in 3 equal annual installments thereafter. Vested shares will be delivered to the Reporting Person on the earlier of (i) the ten-year anniversary of the Grant Date; (ii) sixty days after the date the Grantee's Service ceases for any reason and such cessation constitutes a "separation from service" within the meaning of Section 409A of the Code; (iii) the date of Grantee's death or (iv) the date of a Change in Control that constitutes a "change in control event" within the meaning of Section 409A of the Code. F2 · balance_after: Reflects the cancellation of 2,800,000 Restricted Stock Units pursuant to an RSU Cancellation Agreement, dated December 13, 2016. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 20:57 UTC |
Otis WilliamDirector
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001209191-17-041854 · doc4.xml · derivative · entry 2 Otis William · CIK 0001589472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-06-22 F3 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 20:57 UTC |
Otis WilliamDirector
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041854 · doc4.xml · nonDerivative · entry 1 Otis William · CIK 0001589472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,666 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Vested shares will be delivered to the Reporting Person on the earlier of (i) the ten-year anniversary of the Grant Date; (ii) sixty days after the date the Grantee's Service ceases for any reason and such cessation constitutes a "separation from service" within the meaning of Section 409A of the Code; (iii) the date of Grantee's death or (iv) the date of a Change in Control that constitutes a "change in control event" within the meaning of Section 409A of the Code. F2 · balance_after: Reflects the cancellation of 200,000 Restricted Stock Units pursuant to the RSU Cancellation Agreement between the Issuer and the Reporting Person, dated December 13, 2016. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 20:55 UTC |
Lee Tom YDirector
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001209191-17-041852 · doc4.xml · derivative · entry 2 Lee Tom Y · CIK 0001623609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-06-22 F2 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.